How Do Patents Affect Follow-On Innovation? Evidence from the Human Genome
NBER Working Paper No. 21666
We investigate whether patents on human genes have affected follow-on scientific research and product development. Using administrative data on successful and unsuccessful patent applications submitted to the US Patent and Trademark Office, we link the exact gene sequences claimed in each application with data measuring follow-on scientific research and commercial investments. Using this data, we document novel evidence of selection into patenting: patented genes appear more valuable—prior to being patented—than non-patented genes. This evidence of selection motivates two quasi-experimental approaches, both of which suggest that on average gene patents have had no quantitatively important effect on follow-on innovation.
Document Object Identifier (DOI): 10.3386/w21666
Published: Bhaven Sampat & Heidi L. Williams, 2019. "How Do Patents Affect Follow-On Innovation? Evidence from the Human Genome," American Economic Review, vol 109(1), pages 203-236. citation courtesy of
Users who downloaded this paper also downloaded* these: